Novartis pharma boss expects pressure on cancer drug prices

January 27, 2015 2:24 PM

14 0

ZURICH (Reuters) - Payers are likely to put pressure on drugmakers to lower the cost of cancer medicines, particularly when alternative treatments are available, the head of Novartis' pharma division said on Tuesday.

"I think there will be increased pressure on oncology prices," David Epstein, head of Novartis' pharmaceutical division told an analyst call after the company reported fourth-quarter results.

Read more

To category page